Blog

Starzl TE. History of clinical transplantation. World J Surg. 2000;24(7):759–82.

PubMed 
PubMed Central 

Google Scholar 

Cooper JE. Evaluation and treatment of acute rejection in kidney allografts. Clin J Am Soc Nephrol CJASN. 2020;15(3):430–8.

PubMed 

Google Scholar 

Lusco MA, Fogo AB, Najafian B, Alpers CE. AJKD atlas of renal pathology: acute T-cell–mediated rejection. Am J Kidney Dis. 2016;67(5):e29-30.

PubMed 

Google Scholar 

Naesens M, Roufosse C, Haas M, Lefaucheur C, Mannon RB, Adam BA, et al. The Banff 2022 kidney meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. Am J Transplant. 2024;24(3):338–49.

PubMed 

Google Scholar 

Loupy A, Haas M, Roufosse C, Naesens M, Adam B, Afrouzian M, et al. The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell– and antibody-mediated rejection. Am J Transplant. 2020;20(9):2318–31.

PubMed 
PubMed Central 

Google Scholar 

Nankivell BJ, Agrawal N, Sharma A, Taverniti A, P’Ng CH, Shingde M, et al. The clinical and pathological significance of borderline T cell–mediated rejection. Am J Transplant. 2019;19(5):1452–63.

PubMed 

Google Scholar 

Loupy A, Mengel M, Haas M. Thirty years of the International banff classification for allograft pathology: the past, present, and future of kidney transplant diagnostics. Kidney Int. 2022;101(4):678–91.

PubMed 

Google Scholar 

de Freitas DG, Sellarés J, Mengel M, Chang J, Hidalgo LG, Famulski KS, et al. The nature of biopsies with “borderline rejection” and prospects for eliminating this category. Am J Transplant. 2012;12(1):191–201.

PubMed 

Google Scholar 

Mehta RB, Tandukar S, Jorgensen D, Randhawa P, Sood P, Puttarajappa C, et al. Early subclinical tubulitis and interstitial inflammation in kidney transplantation have adverse clinical implications. Kidney Int. 2020;98(2):436–47.

PubMed 

Google Scholar 

Heilman RL, Nijim S, Chakkera HA, Devarapalli Y, Moss AA, Mulligan DC, et al. Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal. J Transplant. 2011;2011(1):583981.

PubMed 
PubMed Central 

Google Scholar 

Masin-Spasovska J, Spasovski G, Dzikova S, Petrusevska G, Dimova B, Lekovski L, et al. The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsies. Prilozi. 2005;26(1):25–33.

PubMed 

Google Scholar 

Thierry A, Thervet E, Vuiblet V, Goujon JM, Machet MC, Noel LH, et al. Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation. Am J Transplant. 2011;11(10):2153–61.

PubMed 

Google Scholar 

Wang C, Feng G, Zhao J, Xu Y, Li Y, Wang L, et al. Screening of novel biomarkers for acute kidney transplant rejection using DIA-MS based proteomics. PROTEOMICS – Clinical Appl. 2024;18(3):2300047.

Google Scholar 

Heidari SS, Nafar M, Kalantari S, Tavilani H, Karimi J, Foster L, et al. Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: A urinary proteomics analysis. J Proteomics. 2021;30(240):104208.

Google Scholar 

Gwinner W, Karch A, Braesen JH, Khalifa AA, Metzger J, Naesens M, et al. Noninvasive diagnosis of acute rejection in renal transplant patients using mass spectrometric analysis of urine samples: a multicenter diagnostic phase III trial. Transplant Direct. 2022;8(5):e1316.

PubMed 
PubMed Central 

Google Scholar 

Geoui T, Urlaub H, Plessmann U, Porschewski P. Extraction of proteins from formalin-fixed, paraffin-embedded tissue using the qproteome extraction technique and preparation of tryptic peptides for liquid chromatography/mass spectrometry analysis. Current Protocls Mol Biol. 2010;90(1):10–27.

Google Scholar 

Wiśniewski JR, Gaugaz FZ. Fast and sensitive total protein and Peptide assays for proteomic analysis. Anal Chem. 2015;87(8):4110–6.

PubMed 

Google Scholar 

Conover WJ. Practical nonparametric statistics. 3rd ed. New York: Wiley; 1998.

Google Scholar 

Jonckheere AR. A distribution-free k-sample test against ordered alternatives. Biometrika. 1954;41(1–2):133–45.

Google Scholar 

Pallant J. SPSS Survival Manual: A Step by Step Guide to Data Analysis Using SPSS for Windows. 4th ed. McGraw Hill Open University Press; 2010.

Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale; 1988.

Armitage P. Tests for Linear Trends in Proportions and Frequencies. Biometrics. 1955;11(3):375.

Google Scholar 

Fang F, Liu P, Song L, Wagner P, Bartlett D, Ma L, et al. Diagnosis of T-cell-mediated kidney rejection by biopsy-based proteomic biomarkers and machine learning. Front Immunol. 2023;6(14):1090373.

Google Scholar 

Hofstraat R, Marx K, Blatnik R, Claessen N, Chojnacka A, Peters-Sengers H, et al. Highly Repeatable Tissue Proteomics for Kidney Transplant Pathology: Technical and Biological Validation of Protein Analysis using LC-MS/MS. bioRxiv; 2024. p 2024.06.14.599091.

Schmouder RL, Kunkel SL. The cytokine response in renal allograft rejection. Nephrol Dial Transplant. 1995;10(supp1):36–43.

PubMed 

Google Scholar 

De Serres SA, Mfarrej BG, Grafals M, Riella LV, Magee CN, Yeung MY, et al. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol. 2012;7(6):1018.

PubMed 
PubMed Central 

Google Scholar 

Karczewski J, Karczewski M, Glyda M, Wiktorowicz K. Role of TH1/TH2 cytokines in kidney allograft rejection. Transplant Proc. 2008;40(10):3390–2.

PubMed 

Google Scholar 

Biro M, Munoz MA, Weninger W. Targeting Rho-GTPases in immune cell migration and inflammation. Br J Pharmacol. 2014;171(24):5491–506.

PubMed 
PubMed Central 

Google Scholar 

Matsuda J, Asano-Matsuda K, Kitzler TM, Takano T. Rho GTPase regulatory proteins in podocytes. Kidney Int. 2021;99(2):336–45.

PubMed 

Google Scholar 

Kurian SM, Velazquez E, Thompson R, Whisenant T, Rose S, Riley N, et al. Orthogonal comparison of molecular signatures of kidney transplants with subclinical and clinical acute rejection: equivalent performance is agnostic to both technology and platform. Am J Transplant. 2017;17(8):2103–16.

PubMed 
PubMed Central 

Google Scholar 

Kurian SM, Williams AN, Gelbart T, Campbell D, Mondala TS, Head SR, et al. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. Am J Transplant. 2014;14(5):1164–72.

PubMed 
PubMed Central 

Google Scholar 

Zhang M, Chen F, Feng S, Liu X, Wang Z, Shen N, et al. FBLN5 as one presumably prognostic gene potentially modulating tumor immune microenvironment for renal clear cell carcinoma in children and young adults. Pharmacogenomics Pers Med. 2024;19(17):27–40.

Google Scholar 

Huang W, Shi H, Hou Q, Mo Z, Xie X. GSTM1 and GSTT1 polymorphisms contribute to renal cell carcinoma risk: evidence from an updated meta-analysis. Sci Rep. 2015;5(1):17971.

PubMed 
PubMed Central 

Google Scholar 

Li P, Li D, Lu Y, Pan S, Cheng F, Li S, et al. GSTT1/GSTM1 deficiency aggravated cisplatin-induced acute kidney injury via ROS-triggered ferroptosis. Front Immunol. 2024;25(15):1457230.

Google Scholar 

Beothe T, Docs J, Kovacs G, Peterfi L. Increased level of TXNIP and nuclear translocation of TXN is associated with end stage renal disease and development of multiplex renal tumours. BMC Nephrol. 2024;17(25):227.

Google Scholar 

Luczak M, Formanowicz D, Marczak Ł, Pawliczak E, Wanic-Kossowska M, Figlerowicz M, et al. Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry. J Transl Med. 2015;13(1):20.

PubMed 
PubMed Central 

Google Scholar 

Abdullah EL, Jalalonmuhali M, Ng KP, Jamaluddin FA, Lim SK. The role of lymphocyte subset in predicting allograft rejections in kidney transplant recipients. Transplant Proceed. 2022;54(2):312–9.

Google Scholar 

Halloran PF. T cell-mediated rejection of kidney transplants: a personal viewpoint. Am J Transplant. 2010;10(5):1126–34.

PubMed 

Google Scholar 

Liu B, Chen L, Huang H, Huang H, Jin H, Fu C. Prognostic and immunological value of GNB4 in gastric cancer by analyzing TCGA database. Dis Markers. 2022;16(2022):1–16.

Google Scholar 

Zhan J, Huang L, Niu L, Lu W, Sun C, Liu S, et al. Regulation of CD73 on NAD metabolism: unravelling the interplay between tumour immunity and tumour metabolism. Cell Commun Signal. 2024;22(1):387.

PubMed 
PubMed Central 

Google Scholar 

Chen S, Wainwright DA, Wu JD, Wan Y, Matei DE, Zhang Y, et al. Cd73: an emerging checkpoint for cancer immunotherapy. Immunotherapy. 2019;11(11):983–97.

PubMed 
PubMed Central 

Google Scholar 

Antonioli L, Pacher P, Vizi ES, Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19(6):355–67.

PubMed 
PubMed Central 

Google Scholar 

Schneider E, Winzer R, Rissiek A, Ricklefs I, Meyer-Schwesinger C, Ricklefs FL, et al. CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. Nat Commun. 2021;12(1):5911.

PubMed 
PubMed Central 

Google Scholar 

Deutsch EW, Bandeira N, Perez-Riverol Y, Sharma V, Carver JJ, Mendoza L, et al. The proteomexchange consortium at 10 years: 2023 update. Nucleic Acids Res. 2023;51(D1):D1539–48.

PubMed 

Google Scholar 

Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res. 2025;53(D1):D543–53.

PubMed 

Google Scholar